Synergistic effects of olaparib combined with ERCC1 on the sensitivity of cisplatin in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is a common malignant tumor. ERCC excision repair 1 endonuclease non-catalytic subunit (ERCC1) is a key mediator of nucleotide excision repair. The present study aimed to explore the synergistic effects of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Kejie, Ni, Xiaoyan, Lv, Shanmei, Zhou, Guozhong, He, Honger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967929/
https://www.ncbi.nlm.nih.gov/pubmed/33747222
http://dx.doi.org/10.3892/ol.2021.12626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7967929/
https://www.ncbi.nlm.nih.gov/pubmed/33747222
http://dx.doi.org/10.3892/ol.2021.12626

Ejemplares similares